General Information of the Compound
| Compound ID |
CP0016948
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
Show/Hide
|
||||||||||||||||||
| Synonyms |
1,2,4-Thiadiazolidine-3,5-dione, 2-methyl-4-(phenylmethyl)-
1,2,4-Thiadiazolidine-3,5-dione,2-methyl-4-(phenylmethyl)-
327036-89-5
4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
4-Benzyl-2-methyl-[1,2,4]thiadiazolidine-3,5-dione
A Inhibitor I, TDZD-8
AK-48153
AOB6176
BDBM7781
CHEMBL284861
CTK4G9152
DTXSID30399590
EX-A109
GSK-3 Inhibitor I
GSK-3beta Inhibitor I
GTPL5977
HMS3229G12
JDSJDASOXWCHPN-UHFFFAOYSA-N
MFCD04973552
MolPort-003-844-896
NP 01139
SCHEMBL139834
TDZD 8
TDZD-8
ZINC27361
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H10N2O2S
|
||||||||||||||||||
| Molecular Weight |
222.269
|
||||||||||||||||||
| Canonical SMILES |
Cn1sc(=O)n(Cc2ccccc2)c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H10N2O2S/c1-11-9(13)12(10(14)15-11)7-8-5-3-2-4-6-8/h2-6H,7H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
JDSJDASOXWCHPN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound